About Sandika Pharmaceuticals Private Ltd.
Data last updated:
Sandika Pharmaceuticals Private Ltd. is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 August 1987 and has been in existence for over 39 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1987PTC029027. Its GSTIN is 07AAACS1043C1Z1 (Delhi).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Sanjeev Gulati and Radha Umre.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 40 Niti Bagh Dda Sfs Flats Khel Gaon Road Behind Uday Park Taxi S, Tand, New Delhi, Delhi, India – 110049.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.32 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹13.31 Lakh (net margin 3.1%) and EBITDA of ₹25.03 Lakh (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 9% over five years.
As per MCA filings, the company has open charges of ₹1 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sandikapharma.com.
Company details
Contact details
Sandika Pharmaceuticals Private Ltd.'s registered office is in New Delhi, Delhi. Its website is sandikapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address40 Niti Bagh Dda Sfs Flats Khel Gaon Road Behind Uday Park Taxi S, Tand, New Delhi, Delhi, India – 110049
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sandika Pharmaceuticals Private Ltd., buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sandika Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Sandika Pharmaceuticals Private Ltd., buy the company report.
Financials of Sandika Pharmaceuticals Private Ltd.
FY 2025 filings availableSandika Pharmaceuticals Private Ltd. reported revenue of ₹4.32 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 9% growth in the latest year. EBITDA rose 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹25.03 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.31 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sandika Pharmaceuticals Private Ltd., buy the company report.
Board of directors of Sandika Pharmaceuticals Private Ltd.
Sandika Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjeev Gulati | Director | 30 Jun 2022 | 4 Years 3 Months | Current |
| Radha Umre | Director | 01 Apr 1991 | 35 Years 6 Months | Current |
| Sushant Umre Also directs: Dr. Umre's Dental Operatory LLP | Director | 03 Jun 2005 | 21 Years 4 Months | Current |
| Shivi Chawla | Director | 30 Jun 2022 | 4 Years 3 Months | Current |
Auditor
Sandika Pharmaceuticals Private Ltd. is audited by APURV RELAN & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| APURV RELAN & CO. | FY 2023 | 006680N |
Shareholding
The shareholding of Sandika Pharmaceuticals Private Ltd. is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sandika Pharmaceuticals Private Ltd., buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Jul 2001 | 90057508 | Bank of Maharashtra | ₹1 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Sandika Pharmaceuticals Private Ltd. has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Civil suit | Filed against the company by State | Disposed |
To see the full case history of Sandika Pharmaceuticals Private Ltd., buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sandika Pharmaceuticals Private Ltd.; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sandika Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACS1043C1Z1 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sandika Pharmaceuticals Private Ltd., buy the company report.
Recent activity
Sandika Pharmaceuticals Private Ltd. has 6 board changes on record since 1991: 4 appointments and 2 cessations. The latest: Sanjeev Gulati ceased to be Additional Director on 30 Sep 2022.
Frequently asked questions
Sandika Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 August 1987 (39+ years old) and is registered under CIN U74899DL1987PTC029027.
Sandika Pharmaceuticals has 4 current directors:
- Sanjeev Gulati - Director
- Radha Umre - Director
- Sushant Umre - Director
- Shivi Chawla - Director
The latest financial statements of Sandika Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sandika Pharmaceuticals is 07AAACS1043C1Z1, registered in Delhi.
The CIN (Corporate Identification Number) of Sandika Pharmaceuticals is U74899DL1987PTC029027. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sandika Pharmaceuticals has 1 court case on record: 1 filed against it.
Sandika Pharmaceuticals was incorporated on 27 August 1987, making it 39+ years old. It is registered with the Registrar of Companies, Delhi.
Sanjeev Gulati ceased to be Additional Director on 30 Sep 2022. Shivi Chawla ceased to be Additional Director on 30 Sep 2022. Sanjeev Gulati was appointed as Director on 30 Jun 2022. Sandika Pharmaceuticals has 6 board changes on record in total.
Sandika Pharmaceuticals can be reached through the website sandikapharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Sandika Pharmaceuticals is at 40 Niti Bagh Dda Sfs Flats Khel Gaon Road Behind Uday Park Taxi S, Tand, New Delhi, Delhi, India – 110049.